Capital Fund Management (CFM)’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Hold |
|
|||||
|
2025
Q2 | – | Hold |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $712K | Sell |
|
|||||
|
2024
Q3 | $2.35M | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $3.82M | Sell |
|
|||||
|
2023
Q4 | $4.57M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $2.36M | Buy |
|
|||||
|
2023
Q1 | $554K | Sell |
|
|||||
|
2022
Q4 | $2.45M | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $6.33M | Sell |
|
|||||
|
2022
Q1 | $13.7M | Buy |
|
|||||
|
2021
Q4 | $6.75M | Sell |
|
|||||
|
2021
Q3 | $14.1M | Buy |
|
|||||
|
2021
Q2 | $2.35M | Sell |
|
|||||
|
2021
Q1 | $2.55M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $908K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $298K | Buy |
|
|||||
|
2019
Q4 | $211K | Buy |
|
|||||
|
2019
Q1 | – | Hold |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $1.51M | Buy |
|